Successful living-related liver transplantation for familial hypercholesterolemia in the Middle East

Transplant International

Volumn 17, Issue 11, 2004, Pages 735-739

  Khalifeh, Mohamad ^a   Faraj, Walid ^a   Heaton, Nigel ^b   Rela, Mohammad ^b   Sharara, Ala I ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Cholesterol; Genetic; Inborn error of metabolism; Pediatric

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SIMVASTATIN; TACROLIMUS;

AGE DISTRIBUTION; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CORONARY ARTERY BYPASS GRAFT; ECHOCARDIOGRAPHY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; LIVER TRANSPLANTATION; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 17644364765     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00147-004-0791-7     Document Type: Article

References (26)

1. Goldstein JL, Brown MS (1973) Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with over-production of cholesterol. Proc Natl Acad Sci U S A 70:2804-2808
2. Phillips T, Leigh IM. Familial hypercholesterolemia. J R Soc Med 1987; 80:649-651.
3. Scriver CR, Beaudet AL, Sly WS, Valle D. The metabolic basis of inherited disease, 7th edn, vol II. New York: McGraw-Hill, 1995:20.14-20.20.
4. Cienfuegos JA, Pardo F, Turrion VS et al. Metabolic effects of liver replacement in homozygous familial hypercholesterolemia. Transplant Proc 1987; 19:3815-3817.
5. Winters JL, Pineda AA, McLeod BC, Grima KM. Therapeutic aphaeresis in renal and metabolic diseases. J Clin Apheresis 2000; 15:53-73.
6. Ohri SK, Keane PF, Swift I, Sackier JM, Williamson RC, Thompson GR. Reappraisal of partial ileal bypass for the treatment of familial hypercholesterolemia. Am J Gastroenterol 1989; 84:740-743.
7. Faergeman O, Meinertz H, Hylander E, Fischerman K, Jarnum S, Nielsen OV. Effects and side-effects of partial ileal by-pass surgery for familial hypercholesterolaemia. Gut 1982; 23:558-563.
8. Campos CT, Matts JP, Santilli SM, Fitch LL, Long JM, Speech JC, Buchwald H. Predictors of total and low-density lipoprotein cholesterol change after partial ileal bypass. Am J Surg 1988; 155:138-146.
9. . Forman MB, Baker SG, Mieny CJ, Joffe BI, Sandler MP, Mendelsohn DU, Seftel HC. Treatment of homozygous familial hypercholesterolaemia with portacaval shunt. Atherosclerosis 1982; 41:349-361.
10. Bilheimer DW. Metabolic effects of portocaval shunt surgery and liver transplantation in familial hypercholeslerolemia. Beitr Infusionsther 1988; 23:61-73.
11. Guibaud P, Cartailhac Y, Smit G, Parscau L de, Louis D. Portacaval anastomosis in 2 cases of homozygote familial hypercholesterolemia. Pediatric 1986; 41:453-459.
12. Bilheimer DW. Portacaval shunt surgery and liver transplantation in the treatment of homozygous familial hypercholesterolemia. Prog Clin Biol Res 1988; 255:295-304.
13. Starzl TE, Bilheimer DW, Bahnsen HT et al . Heart-liver transplantation in a patient with familial hypercholesterolemia. Lancet 1984; 1 :1382-1383.
14. Figuera D, Ardaiz J, Martin-Judez V et al. Combined transplantation of heart and liver from two different donors in a patient with familial type IIa hypercholesterolemia. J Heart Transplant 1986; 5:327-329.
15. Valdivielso P, Escolar JL, Cuervas-Mons V, Pulpon LA, Chaparro MA, Gonzales-Santos P. Lipids and lipoprotein changes after heart and liver transplantation in a patient with homozygous familial hypercholesterolemia. Ann Intern Med 1988; 108:204-206.
16. Revell SP, Noble-Jamieson G, Johnston P, Rasmussen A, Jamieson N, Barnes ND. Liver transplantation for homozygous familial hypercholesterolemia. Arch Dis Child 1995; 73:456-458.
17. Bilheimer DW, Goldstein JL, Grundy SM, Starzl TE, Brown MS. Liver transplantation to provide low density lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N Engl J Med 1984; 311:1658-1664.
18. Martinez Ibanez V, Margarit C, Tormo R, Infante D, Allende H, Sanchis L, Boix-Ochoa J. New perspectives in liver based metabolic errors: liver transplantation (in Spanish). Cir Pediatr 1989; 2:137-139.
19. Sokal EM, Ulla L, Harvengt C, Otte JB. Liver transplantation for familial hypercholesterolemia before the onset of cardiovascular complications. Transplantation 1993; 55:432-433.
20. Broelsch CE, Emond JC, Whitington PF, Thistlethwaite JR, Baker AL, Lichtor JL. Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg 212; 1990 :368-375.
21. Stangl MJ, Beuers U, Schauer R et al. Allogenic liver transplantation: a form of "gene therapy" in metabolic diseases. Chirurg 2000; 71:808-819.
22. Rasper SE. Hepatocyte transplantation and gene therapy. Clin Transplant 1995; 9:249-254.
23. Ishibashi S, Yamada N. Perspective of gene therapy in hyperlipoproteinemia. Nippon Rinsho 1994; 52:3303-3308.
24. Wilson JM, Chowdhury JR. Prospects for gene therapy of familial hypercholesterolemia. Mol Biol Med 1990; 7:223-232.
25. Brown MS, Goldstein JL, Havel RJ, Steinberg D. Gene therapy for cholesterol. Nat Genet 1994; 7:349-350.
26. Wilson JM, Grossman M, Raper SE, Baker JR, Newton RS, Thoene JG. Ex vivo gene therapy of familial hypercholesterolemia. Hum Gene Ther 1992; 3:179-222.